SciVision Biotech (1786.TW) Earnings Analysis

SciVision Biotech (1786.TW) next reports earnings on 2026-08-06. Last quarter (2026-03-06) it missed with EPS 0.86 TWD vs 1.68 TWD est (-48.8%). It has beaten estimates in 0/4 recent quarters (0%). Trailing P/E 28.97.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 1786.TW next report earnings?

Next earnings date2026-08-06
Consensus EPS estimaten/a
Revenue estimaten/a

1786.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-060.86 TWD1.68 TWD-48.8%Miss
2025-11-130.79 TWD1.48 TWD-46.6%Miss
2025-08-07-0.22 TWD1.08 TWD-120.4%Miss
2025-03-060.84 TWD1.17 TWD-28.2%Miss

Beat rate: 0/4 (0%) over reported quarters with consensus data.

1786.TW valuation and analyst view

Trailing P/E28.97
Trailing EPS1.703 TWD
Price / book2.03
Dividend yield3.79%
Market cap3.74B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is SciVision Biotech (1786.TW)'s next earnings date?

SciVision Biotech is next scheduled to report on 2026-08-06.

Did 1786.TW beat earnings last quarter?

In its 2026-03-06 report, 1786.TW posted EPS of 0.86 TWD versus a 1.68 TWD estimate — a miss of 48.8%.

What is 1786.TW's earnings track record?

Over the last 4 reported quarters with consensus data, 1786.TW beat estimates 0 times (0%).

What is 1786.TW's current P/E ratio and EPS?

1786.TW trades at a trailing P/E of 28.97 on trailing EPS of 1.70301224140696 TWD.

What do analysts rate 1786.TW?

1786.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.